Global Health Limited (MEDANTA) Q2 FY27 Financial Results: PAT ₹1,573 Cr & Revenue ₹13,262 Cr

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
MetricValue
Revenue₹13,262 Cr
Net Profit (PAT)₹1,573 Cr
📢 Key Event
Global Health Limited announced Q1 FY2027 results showing record total income of ₹13,262 crores
🔄 What Changed
26.2% YoY revenue growth; 23.5% YoY EBITDA growth; 1.1% YoY PAT decline; 72 beds added
🔮 What's Next
Expecting to operationalise an 80-bed cancer facility in Indore in the next few months; scaling Guwahati project to 650 beds with INR 9,700 million capex
💡 Investor Takeaway
Strong top-line growth is offset by margin pressure and PAT decline, indicating execution risks in new hospital ramp-ups

Global Health Limited reported Q1 FY2027 consolidated total income of ₹13,262 crores, up 26.2% YoY, with EBITDA at ₹3,153 crores (23.5% YoY growth) and PAT of ₹1,573 crores, down 1.1% YoY due to a one-time reversal of interest liability in the prior year. Occupancy rose to 62.6% with ARPOB at ₹70,244, and 72 new beds were added across Noida and Lucknow. The company highlighted strong volume growth and improved realisations as key drivers of performance.

📄 View Original Announcement (PDF)

About Global Health Limited (MEDANTA)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹33,404.85 Cr P/E: 65.8

View full MEDANTA stock details →

📡 Get AI alerts when MEDANTA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MEDANTA — Free

📊 More MEDANTA filings

See all MEDANTA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MEDANTA files new disclosures

Track MEDANTA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MEDANTA — Free

Free account · 2 AI queries/day